We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
Cap. Flow
-$1.55B
Cap. Flow %
-17.42%
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$37.3M
2
MMP
Magellan Midstream Partners, L.P.
MMP
+$31.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
NEM icon
Newmont
NEM
+$27.4M
5
CMI icon
Cummins
CMI
+$24.3M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$430M
2
JPM icon
JPMorgan Chase
JPM
+$168M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$132M
4
YUM icon
Yum! Brands
YUM
+$105M
5
PFE icon
Pfizer
PFE
+$92.8M

Sector Composition

Rank Sector Weight
1 Energy 59.33%
2 Technology 6.01%
3 Healthcare 4.63%
4 Consumer Discretionary 3.72%
5 Financials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNM icon
976
Unum
UNM
$13.8B
– –
-895,900
Closed -$22.5M
UTF icon
977
Cohen & Steers Infrastructure Fund
UTF
$3.14B
– –
-2,114,058
Closed -$57.3M
UTG icon
978
Reaves Utility Income Fund
UTG
$3.69B
– –
-294,933
Closed -$9.66M
VCEL icon
979
Vericel Corp
VCEL
$2.3B
– –
-57,152
Closed -$2.79M
VICR icon
980
Vicor
VICR
$9.62B
– –
-2,351
Closed -$315K
VIR icon
981
Vir Biotechnology
VIR
$1.47B
– –
-160,089
Closed -$6.97M
VMC icon
982
Vulcan Materials
VMC
$36.3B
– –
-1,689
Closed -$286K
VMEO
983
DELISTED
Vimeo
VMEO
– –
-33,650
Closed -$988K
VSTM icon
984
Verastem
VSTM
$532M
– –
-18,462
Closed -$682K
VTR icon
985
Ventas
VTR
$48.9B
– –
-383,200
Closed -$21.2M
VYX icon
986
NCR Voyix
VYX
$1.06B
– –
-11,733
Closed -$279K
YUM icon
987
Yum! Brands
YUM
$41B
– –
-858,000
Closed -$105M
ZYME icon
988
Zymeworks
ZYME
$1.68B
– –
-56,851
Closed -$1.65M
SPRB
989
Spruce Biosciences
SPRB
$119M
– –
-382
Closed -$172K
CMRX
990
DELISTED
Chimerix, Inc.
CMRX
– –
-105,711
Closed -$654K
SYRS
991
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-7,590
Closed -$339K
GTHX
992
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-51,899
Closed -$696K
MOR
993
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-165,509
Closed -$1.95M
AIRC
994
DELISTED
Apartment Income REIT Corp.
AIRC
– –
-5,419
Closed -$265K
EIGR
995
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-1,387
Closed -$278K
GMDA
996
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
– –
-72,646
Closed -$285K
ORTX
997
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-14,789
Closed -$340K
RTL
998
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
– –
-86,415
Closed -$695K
MTEM
999
DELISTED
Molecular Templates, Inc.
MTEM
– –
-4,588
Closed -$462K
PBFX
1000
DELISTED
PBF LOGISTICS LP
PBFX
– –
-13,931
Closed -$176K
37 38 39
40
41

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.

By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.

Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.

  • ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
  • ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
  • ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
  • ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
  • ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
  • ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
  • ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.